Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans.
about
Fine-mapping the genetic association of the major histocompatibility complex in multiple sclerosis: HLA and non-HLA effectsGenetic analysis of completely sequenced disease-associated MHC haplotypes identifies shuffling of segments in recent human history.Neurodegeneration in multiple sclerosis: novel treatment strategiesMethods for high-density admixture mapping of disease genesA genome-wide analysis of admixture in Uyghurs and a high-density admixture map for disease-gene discoveryAnalysis of genomic admixture in Uyghur and its implication in mapping strategyTranslational utility of experimental autoimmune encephalomyelitis: recent developmentsHLA-associated susceptibility to childhood B-cell precursor ALL: definition and role of HLA-DPB1 supertypesBiomarkers in Multiple Sclerosis: An Up-to-Date OverviewCCL genes in multiple sclerosis and systemic lupus erythematosusHLA-DR15 haplotype and multiple sclerosis: a HuGE reviewHigh-density mapping of the MHC identifies a shared role for HLA-DRB1*01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitisGenome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosisAn ImmunoChip study of multiple sclerosis risk in African Americans.SNP-based analysis of the HLA locus in Japanese multiple sclerosis patients.The efficacy of short tandem repeat polymorphisms versus single-nucleotide polymorphisms for resolving population structure.Variation of the myelin oligodendrocyte glycoprotein gene is not primarily associated with multiple sclerosis in the Sardinian population.Defining the role of the MHC in autoimmunity: a review and pooled analysisAssociation between protective and deleterious HLA alleles with multiple sclerosis in Central East Sardinia.Genetic analysis of the exon 1 position 49 CD152 dimorphism in multiple sclerosisA major histocompatibility Class I locus contributes to multiple sclerosis susceptibility independently from HLA-DRB1*15:01.The genetic aspects of multiple sclerosis.MultiRTA: a simple yet reliable method for predicting peptide binding affinities for multiple class II MHC allotypes.The genetic basis of multiple sclerosis: a model for MS susceptibility.Towards universal structure-based prediction of class II MHC epitopes for diverse allotypes.CIITA variation in the presence of HLA-DRB1*1501 increases risk for multiple sclerosis.Multiple sclerosis susceptibility alleles in African Americans.A high-resolution linkage-disequilibrium map of the human major histocompatibility complex and first generation of tag single-nucleotide polymorphisms.Refining the association of MHC with multiple sclerosis in African Americans.HLA-DRB1 may be antagonistically regulated by the coordinately evolved promoter and 3'-UTR under stabilizing selectionPerspectives on the use of multiple sclerosis risk genes for predictionEvidence for CRHR1 in multiple sclerosis using supervised machine learning and meta-analysis in 12,566 individuals.HLA-DRB1-DQB1 haplotypes confer susceptibility and resistance to multiple sclerosis in Sardinia.Primary sclerosing cholangitis in genetically diverse populations listed for liver transplantation: unique clinical and human leukocyte antigen associationsLate onset myasthenia gravis is associated with HLA DRB1*15:01 in the Norwegian population.DQB1*06:02-Associated Pathogenic Anti-Myelin Autoimmunity in Multiple Sclerosis-Like Disease: Potential Function of DQB1*06:02 as a Disease-Predisposing AlleleThe immunological basis for treatment of multiple sclerosis.Refinement of the MHC risk map in a scandinavian primary sclerosing cholangitis population.T cell receptor recognition of self and foreign antigens in the induction of autoimmunity.Male microchimerism in peripheral blood leukocytes from women with multiple sclerosis.
P2860
Q21090198-D157770C-93ED-4EF1-B7EC-838251828B43Q21145273-D2020562-6170-4FBB-9163-6FDC12FD8F50Q22241472-95D5CA24-26FC-4B5C-BDED-30043816D363Q22337164-A1340B19-1B36-4756-BF95-65A37D0B7C81Q24642258-8AD0CCEB-B3CA-4AE3-9BB6-D3542FB94CBBQ24656012-E66DC68A-9B9B-4B17-A959-BA89D2A526BEQ26775820-0FB51D60-513A-4B2E-A187-1EB094C263DCQ27485629-EFA87B1E-32B3-4B69-BCD1-907859D903D7Q27496017-27A399DB-292B-44F4-8F0A-D0C0A47CF727Q28286163-90A21FDD-563B-4277-86EF-90B8ECBB7D24Q28290714-591383F7-26F6-411A-9F4E-1913C2C7E979Q28651183-9B6146F3-CBF3-48A8-8DF7-FE9B0F6CB5BBQ28943261-327075AB-36FA-4A26-984B-6AAB0DF9520FQ30300285-40EE9223-B9CC-47A8-BE78-3CCC9F199F73Q30514239-32C5D0DC-3CB5-48F2-AF01-07BA6614F5BDQ30807420-94FB8BE8-4963-44C1-9DB6-37E883DD4121Q33284956-9D3E7436-D92B-46C8-9ABD-3B12E468E1EBQ33330857-DB1A3B42-4DE7-4EE1-B5BE-CA043B672536Q33490625-98A68089-C4EE-45F3-A14A-DA0466253D7FQ33614772-3E32C1E9-4667-4C71-911C-39B987C5BCDEQ33622435-07732845-1D17-481A-B835-D3BDFB1F6B08Q33670899-59D28650-A99F-4873-B847-5A7375ECAC72Q33702755-1F1335C1-B79E-4FA8-8E35-C6FCAE768D78Q33732130-1A17DB98-1CCC-4D35-8967-AD99B1C5EE59Q33781091-B65D11D0-BBCC-4987-AE0A-5186113DD923Q33832877-9044904A-5A7D-4ABA-A09F-28DED9E82AA0Q33892035-0434248B-691C-4C3D-9492-83C3EEE95C06Q33942154-288CCFF2-8986-4BBD-ADD6-D9B02F1578B8Q33980298-9E41CA67-54B7-4489-BEFA-827065195A6EQ34058319-8B5C1DC7-6A85-4850-8E97-1392FCD00556Q34098864-CB9C0BCA-F7E4-433A-AC19-B2F663519C8AQ34184766-665BFF9B-5810-45B7-AF90-D91EEC230C54Q34235080-30F7855E-24D5-4D1C-9685-A3BACB53A2A6Q34257876-39EEFB3F-8C8D-48A1-BEA0-39D2AD6A7E33Q34270872-1EA02A3D-77F6-4374-8E9E-C63AC73D5F57Q34349507-EC24B6DF-0FEA-415C-B46C-62163DE25D7EQ34582895-A6C6DAF1-0E28-4049-BD57-6BEA0BC470ECQ34733835-B16D5A36-24B5-4FD7-8EBB-F48475B8ED03Q34777861-B705A2EC-CE76-47C6-A80A-1451F0DF029BQ34890939-33033288-D52A-4598-B494-55DE7AE798FF
P2860
Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans.
description
2003 nî lūn-bûn
@nan
2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans
@nl
Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans.
@ast
Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans.
@en
Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans.
@en-gb
type
label
Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans
@nl
Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans.
@ast
Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans.
@en
Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans.
@en-gb
prefLabel
Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans
@nl
Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans.
@ast
Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans.
@en
Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans.
@en-gb
P2093
P2860
P50
P356
P1476
Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans.
@en
P2093
Amy Swerdlin
Bruce A C Cree
David E Reich
Douglas Goodin
Glenys Thomson
Henry A Erlich
Jorge R Oksenberg
Lisa F Barcellos
P2860
P304
P356
10.1086/380997
P407
P577
2003-12-10T00:00:00Z